Home > Cashflow Statement > BETA DRUGS

BETA DRUGS
Cashflow Statement

BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹62 Cr₹49 Cr₹41 Cr₹34 Cr₹16 Cr
Adjustment ₹-6.37 Cr₹-4.25 Cr₹2.02 Cr₹5.10 Cr₹6.54 Cr
Changes In working Capital ₹-19 Cr₹-14 Cr₹-20 Cr₹-9.77 Cr₹-3.89 Cr
Cash Flow after changes in Working Capital ₹36 Cr₹31 Cr₹23 Cr₹30 Cr₹19 Cr
Cash Flow from Operating Activities ₹36 Cr₹31 Cr₹23 Cr₹30 Cr₹19 Cr
Cash Flow from Investing Activities ₹-36 Cr₹-14 Cr₹-19 Cr₹-22 Cr₹-5.85 Cr
Cash Flow from Financing Activities ₹118 Cr₹-7.49 Cr₹-2.47 Cr₹-0.97 Cr₹-7.71 Cr
Net Cash Inflow / Outflow ₹118 Cr₹9.47 Cr₹1.84 Cr₹6.90 Cr₹5.04 Cr
Opening Cash & Cash Equivalents ₹29 Cr₹19 Cr₹17 Cr₹10 Cr₹5.39 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹147 Cr₹29 Cr₹19 Cr₹17 Cr₹10 Cr

Compare Cashflow Statement of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,625.2 Cr 5.9% 9.8% 39.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹470,270.0 Cr -1.5% 2.5% 14.5% Stock Analytics
DIVIS LABORATORIES ₹222,224.0 Cr 7.4% 22.2% 26.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,325.0 Cr 3.1% 4.3% 38.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.6% -1.4% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,876.6 Cr 1.5% -15.2% -9.1% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

5.9%

9.8%

39.5%

SENSEX

2.2%

0.9%

-3.7%


You may also like the below Video Courses